Convergence Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Convergence Investment Partners’s Portfolio REGN Stock Details REGN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$674K	Buy
2024 Q3	–	Sell
2024 Q2	$201K	Buy
2023 Q4	–	Sell
2023 Q3	$245K	Buy
2022 Q3	–	Sell
2022 Q2	$371K	Sell
2022 Q1	$501K	Buy
2021 Q4	$392K	Buy
2018 Q2	–	Sell
2018 Q1	$41K	Buy